MXPA05012675A - Compuestos de hidroxiamidina e hidroxiguanidina como inhibidores de urocinasa. - Google Patents
Compuestos de hidroxiamidina e hidroxiguanidina como inhibidores de urocinasa.Info
- Publication number
- MXPA05012675A MXPA05012675A MXPA05012675A MXPA05012675A MXPA05012675A MX PA05012675 A MXPA05012675 A MX PA05012675A MX PA05012675 A MXPA05012675 A MX PA05012675A MX PA05012675 A MXPA05012675 A MX PA05012675A MX PA05012675 A MXPA05012675 A MX PA05012675A
- Authority
- MX
- Mexico
- Prior art keywords
- hydroxyamidine
- urokinase
- compounds
- hydroxyguanidine
- urokinase inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invencion se relaciona con compuestos novedosos para inhibir al activador de plasminogeno de urocinasa (uPA, por sus siglas en ingles) el cual tiene alta biodisponibilidad y susceptibilidad de administracion oral, y tambien con el uso del mismo como compuestos terapeuticos activos para el tratamiento de trastornos relacionados con urocinasa o/y receptor de urocinasa tales como, por ejemplo, tumores y formacion de metastasis. En particular, la invencion se relaciona con compuestos que contienen grupos hidroxiamidina o hidroxiguanidina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10323898A DE10323898A1 (de) | 2003-05-26 | 2003-05-26 | Hydroxyamidin- und Hydroxyguanidin-Verbindungen als Urokinase-Hemmstoffe |
PCT/EP2004/005682 WO2004103984A1 (de) | 2003-05-26 | 2004-05-26 | Hydroxyamidin- und hydroxyguanidin-verbindungen als urokinase-hemmstoffe |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05012675A true MXPA05012675A (es) | 2006-02-22 |
Family
ID=33461890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05012675A MXPA05012675A (es) | 2003-05-26 | 2004-05-26 | Compuestos de hidroxiamidina e hidroxiguanidina como inhibidores de urocinasa. |
Country Status (15)
Country | Link |
---|---|
US (3) | US7608623B2 (es) |
EP (2) | EP1628965B1 (es) |
JP (1) | JP4621676B2 (es) |
CN (2) | CN1795183B (es) |
AU (2) | AU2004240771B2 (es) |
BR (1) | BRPI0410663B8 (es) |
CA (1) | CA2526989C (es) |
DE (1) | DE10323898A1 (es) |
DK (1) | DK1628965T3 (es) |
ES (1) | ES2550611T3 (es) |
HU (1) | HUE025940T2 (es) |
MX (1) | MXPA05012675A (es) |
PL (1) | PL1628965T3 (es) |
PT (1) | PT1628965E (es) |
WO (1) | WO2004103984A1 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE50310038D1 (de) * | 2002-03-11 | 2008-08-07 | Curacyte Ag | Hemmstoffe der urokinase, ihre herstellung und verwendung |
DE10301300B4 (de) * | 2003-01-15 | 2009-07-16 | Curacyte Chemistry Gmbh | Verwendung von acylierten 4-Amidino- und 4-Guanidinobenzylaminen zur Inhibierung von Plasmakallikrein |
DE10342108A1 (de) * | 2003-09-11 | 2005-04-14 | Curacyte Chemistry Gmbh | Basisch-substituierte Benzylaminanaloga als Inhibitoren des Gerinnungsfaktors Xa, ihre Herstellung und Verwendung |
DE102004045720A1 (de) * | 2004-09-21 | 2006-03-23 | Wilex Ag | Stabile Dosierungsform von Phenylalanin-Derivaten |
DE102004057195A1 (de) * | 2004-11-26 | 2006-06-01 | Wilex Ag | Kristalline Modifikationen von N-Alpha-(2,4,6-Triisopropylphenylsulfonyl)-3-hydroxyamidino-(L)-phenylalanin-4-ethoxycarbonylpiperazid und/oder Salzen davon |
DE602006009257D1 (de) | 2005-06-24 | 2009-10-29 | Wilex Ag | Verwendung von urokinase-inhibitoren zur behandlunklerose (als) |
DE102006050672A1 (de) * | 2006-10-24 | 2008-04-30 | Curacyte Discovery Gmbh | Hemmstoffe des Plasmins und des Plasmakallikreins |
US20080226624A1 (en) * | 2007-03-07 | 2008-09-18 | Wolfgang Schmalix | Combined treatment of cancer by urokinase inhibition and a cytostatic anti-cancer agent for enhancing the anti-metastatic effect |
JPWO2008143342A1 (ja) * | 2007-05-23 | 2010-08-12 | 大日本住友製薬株式会社 | 3−アミノ−2,5−ジオキソピロリジン誘導体の製造方法 |
US9662308B2 (en) | 2008-02-01 | 2017-05-30 | Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co. Kg | Orally bioavailable pentamidine prodrugs for the treatment of diseases |
DE102008007440A1 (de) | 2008-02-01 | 2009-08-13 | Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co.Kg | Aminosäurederivate als Arzneistoffe |
DE102008007381A1 (de) * | 2008-02-01 | 2009-08-13 | Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co.Kg | Amidine und Guanidine und deren Derivate zur Behandlung von Krankheiten |
CN102319241B (zh) * | 2011-07-06 | 2016-02-10 | 中山大学 | 一种针对ccl18靶标的化合物在制备抗乳腺癌药物中的应用 |
DE102011108346A1 (de) * | 2011-07-25 | 2013-01-31 | Philipps-Universität Marburg | Verwendung von Hemmstoffen der TMPRSS2 als Arzneimittel |
US9844540B2 (en) | 2015-10-06 | 2017-12-19 | Redhill Biopharma Ltd. | Combination therapies for treating cancer |
CN110785172A (zh) * | 2017-07-21 | 2020-02-11 | 红山生物医药有限公司 | Wx-uk1及其产品wx-671用于治疗非癌性医学病症的用途 |
MX2022011173A (es) | 2020-03-10 | 2022-10-18 | Redhill Biopharma Ltd | Tratamiento de infeccion por coronavirus. |
US11471448B2 (en) | 2020-12-15 | 2022-10-18 | Redhill Biopharma Ltd. | Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia |
CN114105910B (zh) * | 2021-11-02 | 2024-04-12 | 北京悦康科创医药科技股份有限公司 | 一种羟基脒基苯丙氨酸衍生物、药物组合物与用途 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5629327A (en) | 1993-03-01 | 1997-05-13 | Childrens Hospital Medical Center Corp. | Methods and compositions for inhibition of angiogenesis |
DE4321444A1 (de) | 1993-06-28 | 1995-01-05 | Bernd Prof Dr Clement | Pharmazeutische Zubereitung |
JP2852192B2 (ja) | 1994-07-08 | 1999-01-27 | カンセアフォースクニングスフォンデン・アフ・1989(フォンデン・チル・フレメ・アフ・エクスペリメンテル・カンセアフォースクニング) | uPARのドメイン2+3のuPA結合部位および抗体 |
DE59903981D1 (de) | 1998-07-20 | 2003-02-13 | Wilex Ag | Neue urokinase-inhibitoren |
ES2188003T3 (es) * | 1998-09-18 | 2003-06-16 | Pentapharm Ag | Inhibidores de la uroquinasa. |
DE10029014A1 (de) | 2000-06-15 | 2001-12-20 | Univ Schiller Jena | Urokinase-Hemmstoffe |
US6410005B1 (en) * | 2000-06-15 | 2002-06-25 | Pmd Holdings Corp. | Branched/block copolymers for treatment of keratinous substrates |
US20030125233A1 (en) | 2000-06-27 | 2003-07-03 | Peter Carmeliet | Use of urokinase inhibitors for the treatment and/or prevention of pulmonary hypertension and/or cardiac remodelling |
IL149042A0 (en) | 2000-08-11 | 2002-11-10 | Corvas Int Inc | Non-covalent inhibitors of urokinase and blood vessel formation |
DE60034447T2 (de) * | 2000-08-11 | 2008-02-14 | Wilex Ag | Nicht-kovalente Urokinase-und Angiogenese-Inhibitoren |
US6642252B2 (en) * | 2000-11-07 | 2003-11-04 | Bristol-Myers Squibb Company | Acid derivatives useful as serine protease inhibitors |
EP1360493A1 (en) * | 2001-02-07 | 2003-11-12 | Graffinity Pharmaceutical Design GmbH | Screening method using solid supports modified with self-assembled monolayers |
ATE386029T1 (de) * | 2001-03-21 | 2008-03-15 | Wilex Ag | Urokinase-inhibitoren |
CH695999A5 (de) | 2002-02-28 | 2006-11-15 | Wilex Ag | Verfahren zur Herstellung von 3- Amidinophenylalanin-Derivaten. |
EP1525195A2 (de) | 2002-07-25 | 2005-04-27 | Wilex AG | Verfahren zur herstellung von phenylalanin-derivaten |
-
2003
- 2003-05-26 DE DE10323898A patent/DE10323898A1/de not_active Ceased
-
2004
- 2004-05-26 EP EP04734821.4A patent/EP1628965B1/de active Active
- 2004-05-26 AU AU2004240771A patent/AU2004240771B2/en not_active Ceased
- 2004-05-26 CN CN2004800145217A patent/CN1795183B/zh active Active
- 2004-05-26 WO PCT/EP2004/005682 patent/WO2004103984A1/de active Application Filing
- 2004-05-26 CA CA2526989A patent/CA2526989C/en active Active
- 2004-05-26 PT PT47348214T patent/PT1628965E/pt unknown
- 2004-05-26 DK DK04734821.4T patent/DK1628965T3/en active
- 2004-05-26 ES ES04734821.4T patent/ES2550611T3/es active Active
- 2004-05-26 CN CN201010143428A patent/CN101791394A/zh active Pending
- 2004-05-26 EP EP10163579A patent/EP2243774A1/de not_active Withdrawn
- 2004-05-26 HU HUE04734821A patent/HUE025940T2/en unknown
- 2004-05-26 PL PL04734821T patent/PL1628965T3/pl unknown
- 2004-05-26 BR BRPI0410663A patent/BRPI0410663B8/pt not_active IP Right Cessation
- 2004-05-26 MX MXPA05012675A patent/MXPA05012675A/es active IP Right Grant
- 2004-05-26 JP JP2006529927A patent/JP4621676B2/ja active Active
-
2005
- 2005-11-28 US US11/287,480 patent/US7608623B2/en active Active
-
2008
- 2008-04-18 US US12/105,975 patent/US7807681B2/en active Active
-
2009
- 2009-05-06 AU AU2009201816A patent/AU2009201816A1/en not_active Abandoned
- 2009-09-14 US US12/558,790 patent/US20100068272A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2526989C (en) | 2012-12-04 |
BRPI0410663B8 (pt) | 2021-05-25 |
DE10323898A1 (de) | 2004-12-23 |
AU2009201816A1 (en) | 2009-05-28 |
US7807681B2 (en) | 2010-10-05 |
ES2550611T3 (es) | 2015-11-11 |
JP4621676B2 (ja) | 2011-01-26 |
CA2526989A1 (en) | 2004-12-02 |
EP1628965B1 (de) | 2015-07-22 |
AU2004240771B2 (en) | 2009-02-19 |
EP1628965A1 (de) | 2006-03-01 |
US20060142305A1 (en) | 2006-06-29 |
BRPI0410663B1 (pt) | 2019-05-21 |
DK1628965T3 (en) | 2015-11-02 |
WO2004103984A1 (de) | 2004-12-02 |
CN1795183B (zh) | 2010-04-28 |
US20100068272A1 (en) | 2010-03-18 |
JP2007513062A (ja) | 2007-05-24 |
US7608623B2 (en) | 2009-10-27 |
PL1628965T3 (pl) | 2016-02-29 |
EP2243774A1 (de) | 2010-10-27 |
AU2004240771A1 (en) | 2004-12-02 |
CN1795183A (zh) | 2006-06-28 |
HUE025940T2 (en) | 2016-05-30 |
US20080261998A1 (en) | 2008-10-23 |
CN101791394A (zh) | 2010-08-04 |
BRPI0410663A (pt) | 2006-06-20 |
PT1628965E (pt) | 2015-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05012675A (es) | Compuestos de hidroxiamidina e hidroxiguanidina como inhibidores de urocinasa. | |
IL260127B (en) | mek inhibitors and methods of using them | |
MX2022015272A (es) | Inhibidores de la proteina kras g12c y usos de estos. | |
EP1562897A4 (en) | PHENYL ACARBOXAMIDE AS A BETA SEKRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER | |
HK1080459A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
MXPA02012272A (es) | Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv. | |
DE60324183D1 (en) | Aryl-, aryloxy- und alkyloxysubstituierte 1h-indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1) | |
YU84603A (sh) | Novi inhibitori tirozin kinaze | |
TW200615266A (en) | Organic compounds | |
TW200510375A (en) | New compounds | |
MY143466A (en) | Inhibitors of tyrosine kinases | |
MY148480A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
YU65804A (sh) | Nova heterociklična jedinjenja aktivna kao inhibitori beta-laktamaze | |
MXPA05013224A (es) | Piridinilcarbamatos como inhibidores de lipasa sensible a hormonas. | |
MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
MX2008013836A (es) | Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos. | |
EP1841426A4 (en) | TERTIARY CARBINAMINES INCLUDING SUBSTITUTED HETEROCYCLES AS BETA SECRETASE INHIBITORS AND FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
MY138708A (en) | Biaryloxymethylarenecarboxylic acids | |
GB0112348D0 (en) | Compounds | |
EP1817312A4 (en) | MACROCYCLIC AMINIOPYRIDYL BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER | |
SG158863A1 (en) | Intravenous formulations of pde-5 inhibitors | |
WO2003106381A3 (en) | ADAM 10 HUMAN INHIBITORS | |
AU2003278667A1 (en) | Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines | |
TW200621773A (en) | Bicyclononene derivatives | |
MX2022013615A (es) | Inhibidores de macrociclo de peptidilarginina deiminasas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |